Cite
HARVARD Citation
Janssen, Q. et al. (2019). Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis. Journal of the National Cancer Institute. pp. 782-794. [Online].